Conductive Biomaterials

FACTS identifies 43 companies, but the named startup is Regemat 3D Ltd, based in Spain and focused on 3D bioprinting for regenerative therapies. Related research explores printable cellulose-based conductive hydrogels containing reduced graphene oxide for neural tissue engineering. The dataset does not identify a broad list of manufacturers or suppliers, so company names should not be inferred from research affiliations.

Chinese Academy of Sciences CAS (26 documents) and University of Sichuan (24) have the highest recent counts among the named research organizations in the 24-month window, followed by University of Chinese Academy of Sciences (18). Their work includes tough conductive hydrogels, self-driven myoelectric repair materials and adhesive hydrogels for nerve regeneration.

Recorded grant funding since 2020 totals $14,964,165 across 27 grants. Separately, the funding-round dataset reports $1,060,617,824 across 16 rounds, but entries include broad institutional and infrastructure items rather than clearly dedicated conductive-biomaterials financing. Treat the round aggregate cautiously; the grant total is the more direct measure available in FACTS.

The largest named patent-holder counts are tied at 2 patents each: Harvard University, Tufts University, University of Porto, Instituto Tecnologico de La Energia Ite, Globus Medical, Ucl Business Plc, Imam Abdulrahman Bin Faisal University, and Rede De Quimica E Tecnologia (Requimte ). FACTS does not show a dominant owner.

FACTS shows declining patent activity: 43 patents are counted over the last 24 months, with patent growth at -73.5%. By contrast, publication output reached 670 in the last year and grew 53.3%. This divergence suggests research output is expanding faster than patenting, though it does not establish commercial readiness.

Recent work includes Tsinghua University’s October 2026 publication on electroactive biomaterials that modulate ion channels in nervous-system regeneration, and an August 2026 Tel Aviv University study of a peptide–MXene–hyaluronic-acid conductive scaffold under electrical stimulation. National Research Council Italy also reported PEDOT/polyurethane membranes for electrically and redox-responsive peptide delivery in August 2026.

Main approaches include conducting polymers, carbon nanomaterial composites, conductive hydrogels, metal and inorganic fillers, and functionalized biopolymers. They differ in how they create electrical activity and the properties they bring to a scaffold. Polymer and hydrogel systems can suit soft interfaces, while fillers can add conductive or piezoelectric function; each approach must balance electrical performance with biological compatibility and material stability.

The United States leads with 1,790 documents, followed by China with 1,489 and the United Kingdom with 570. These country totals indicate where indexed activity is concentrated; they do not isolate companies from university research. Research outputs are also prominent in India (559) and Germany (514).

Applications include tissue engineering (423 documents), biosensing and wearables (199), wound healing (150), neural interfaces (115), and cardiac applications (77). The work spans electrically active scaffolds, wound microenvironment modulation, soft signal-acquisition interfaces and regenerative cardiac patches. These are mapped application areas, not necessarily validated clinical products.